Device Trial Radar · NCT05198219
Procedural Efficiency and Organisational Impact of Rhino Laryngoscopes Procedures in Consults
Last checked: Nov 19, 2026Latest source record: Mar 15, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
50
Planned (sponsor's estimate)
Start
Jan 31, 2022
Primary completion
Apr 30, 2022
Study completion Sep 1, 2022
Sponsor
- Lead sponsor
- Ambu A/SNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Sahlgrenska University Hospital; Skane University Hospital
- First posted
- Jan 20, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this study is to investigate the procedure efficiency, organisational and economic impact, and physician evaluation of the conventional reusable rhino laryngoscope vs. Ambu® aScope™ 4 RhinoLaryngo in procedures conducted distally form the ENT department e.g. in the emergency department (ED), intensive care unit (ICU), ward etc., i.e. consults.
Conditions
- Laryngeal Disease
Interventions
Ambu® aScope™ 4 RhinolaryngoDevice
Patient indication following a rhinolaryngoscopy
Conventional reusable rhinolaryngoscopeDevice
Patient indication following a rhinolaryngoscopy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pre-procedure time from notification of the physician to start of rhinolaryngoscopy.Time frame: Prior to procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ambu A/S
Ballerup Municipality, Capital Region, Denmark · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.